PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study | Zendy

AI Assistant Blog Pricing

PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.